Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05048329 · ClinicalTrials.gov registry record · NA

The Cascade Feasibility Pilot (Ileostomy)

A NA study, sponsored by Endeavor Health.

Completed
Registry status
NA
Development phase
11
Enrollment target

NCT05048329: Completed NA study, sponsored by Endeavor Health.

NCT05048329 is a NA study that has completed, run by Endeavor Health. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05048329, a NA study, has completed, sponsored by Endeavor Health.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target

Study Summary

Existing interventions including improving communication and self-care to improve readmission of patients undergoing high risk colorectal surgery involving new ileostomy formation has shown limited results. Our proposal is to deploy a wearable solution that predicts physiological perturbation with continuous remote patient monitoring and advanced machine learning algorithms which will be connected to structured, cascading, escalation pathways and care coordination involving home health nurses, colorectal and ostomy nurses, and colorectal surgeons, and has the potential to transform surgical management in the post-discharge period, where patients are the most vulnerable for readmission. This feasibility study will contribute to the understanding of post-discharge continuous remote monitoring of ileostomy patients, promote patient self-care, and has the potential of improving patient outcomes.

Primary Outcome

Drop out from study

Interventions

  • OTHER Non-invasive continuous remote monitoring with structured escalation pathway
  • OTHER Affective Analysis of Participant Response to Continuous Remote Patient Monitoring

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2021-08-09
Est. Completion 2022-08-31
Phase NA
Endeavor Health

94 total trials

What the finished NCT05048329 record still lists

NCT05048329 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Non-invasive continuous remote monitoring with structured escalation pathway is the first listed.

NCT05048329 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05048329 about?

NCT05048329 is a clinical study titled "The Cascade Feasibility Pilot (Ileostomy)". Existing interventions including improving communication and self-care to improve readmission of patients undergoing high risk colorectal surgery involving new ileostomy formation has shown limited results. Our proposal is to deploy a wearable solution that predicts physiological perturbation with c...

What is the current status of trial NCT05048329?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2021-08-09. Estimated completion is 2022-08-31.

What interventions are being tested in trial NCT05048329?

The interventions under investigation include: Non-invasive continuous remote monitoring with structured escalation pathway (OTHER), Affective Analysis of Participant Response to Continuous Remote Patient Monitoring (OTHER).

Who is sponsoring clinical trial NCT05048329?

This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05048329's enrollment target sits among peer trials

11 1927th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05048329, the US trial registry maintained by the National Library of Medicine. NCT05048329 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.